Bank of New York Mellon’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.4M | Sell |
113,854
-13,002
| -10% | -$3.69M | 0.01% | 1312 |
|
|
2026
Q1 | $35.4M | Sell |
126,856
-2,498
| -2% | -$719K | 0.01% | 1213 |
|
|
2025
Q4 | $39.2M | Sell |
129,354
-3,859
| -3% | -$1.2M | 0.01% | 1158 |
|
|
2025
Q3 | $37.4M | Sell |
133,213
-2,600
| -2% | -$708K | 0.01% | 1192 |
|
|
2025
Q2 | $32.8M | Sell |
135,813
-67,000
| -33% | -$15.8M | 0.01% | 1240 |
|
|
2025
Q1 | $49.4M | Sell |
202,813
-64,493
| -24% | -$19.4M | 0.01% | 975 |
|
|
2024
Q4 | $87.8M | Sell |
267,306
-2,041
| -0.8% | -$693K | 0.02% | 693 |
|
|
2024
Q3 | $90.1M | Buy |
269,347
+72,526
| +37% | +$23M | 0.02% | 698 |
|
|
2024
Q2 | $53.8M | Buy |
196,821
+41,461
| +27% | +$12.1M | 0.01% | 985 |
|
|
2024
Q1 | $53.7M | Buy |
155,360
+21,445
| +16% | +$7.05M | 0.01% | 989 |
|
|
2023
Q4 | $43.2M | Sell |
133,915
-6,371
| -5% | -$2M | 0.01% | 1136 |
|
|
2023
Q3 | $50.3M | Sell |
140,286
-7,517
| -5% | -$2.9M | 0.01% | 974 |
|
|
2023
Q2 | $56M | Sell |
147,803
-13,721
| -8% | -$5.58M | 0.01% | 948 |
|
|
2023
Q1 | $77.4M | Sell |
161,524
-5,039
| -3% | -$2.36M | 0.02% | 741 |
|
|
2022
Q4 | $70M | Sell |
166,563
-21,990
| -12% | -$8.88M | 0.02% | 782 |
|
|
2022
Q3 | $78.7M | Sell |
188,553
-8,278
| -4% | -$4.13M | 0.02% | 687 |
|
|
2022
Q2 | $97.4M | Buy |
196,831
+3,904
| +2% | +$2.03M | 0.02% | 609 |
|
|
2022
Q1 | $109M | Sell |
192,927
-4,232
| -2% | -$2.55M | 0.02% | 635 |
|
|
2021
Q4 | $149M | Sell |
197,159
-5,066
| -3% | -$3.79M | 0.03% | 541 |
|
|
2021
Q3 | $151M | Sell |
202,225
-41,800
| -17% | -$31.3M | 0.03% | 501 |
|
|
2021
Q2 | $157M | Buy |
244,025
+65,331
| +37% | +$39.8M | 0.03% | 495 |
|
|
2021
Q1 | $102M | Sell |
178,694
-3,037
| -2% | -$1.8M | 0.02% | 684 |
|
|
2020
Q4 | $106M | Sell |
181,731
-5,704
| -3% | -$3.25M | 0.02% | 623 |
|
|
2020
Q3 | $96.6M | Buy |
187,435
+5,698
| +3% | +$2.89M | 0.02% | 581 |
|
|
2020
Q2 | $82.1M | Sell |
181,737
-66,618
| -27% | -$29.4M | 0.02% | 625 |
|
|
2020
Q1 | $87.1M | Buy |
248,355
+1,284
| +0.5% | +$472K | 0.03% | 514 |
|
|
2019
Q4 | $91.4M | Sell |
247,071
-12,489
| -5% | -$4.4M | 0.02% | 639 |
|
|
2019
Q3 | $86.4M | Sell |
259,560
-8,333
| -3% | -$2.72M | 0.02% | 646 |
|
|
2019
Q2 | $83.7M | Sell |
267,893
-13,259
| -5% | -$3.97M | 0.02% | 678 |
|
|
2019
Q1 | $85.9M | Buy |
281,152
+10,225
| +4% | +$2.76M | 0.02% | 662 |
|
|
2018
Q4 | $62.9M | Buy |
270,927
+39,571
| +17% | +$10.6M | 0.02% | 754 |
|
|
2018
Q3 | $72.4M | Buy |
231,356
+14,408
| +7% | +$4.47M | 0.02% | 787 |
|
|
2018
Q2 | $62.6M | Sell |
216,948
-3,107
| -1% | -$858K | 0.02% | 849 |
|
|
2018
Q1 | $55M | Sell |
220,055
-15
| -0% | -$3.82K | 0.02% | 934 |
|
|
2017
Q4 | $52.5M | Sell |
220,070
-23,491
| -10% | -$5.69M | 0.01% | 984 |
|
|
2017
Q3 | $54.1M | Sell |
243,561
-5,379
| -2% | -$1.21M | 0.01% | 939 |
|
|
2017
Q2 | $56.3M | Buy |
248,940
+4,004
| +2% | +$873K | 0.02% | 893 |
|
|
2017
Q1 | $48.8M | Buy |
244,936
+15,496
| +7% | +$2.98M | 0.01% | 978 |
|
|
2016
Q4 | $41.8M | Buy |
229,440
+8,041
| +4% | +$1.37M | 0.01% | 1046 |
|
|
2016
Q3 | $36.3M | Buy |
221,399
+2,452
| +1% | +$372K | 0.01% | 1068 |
|
|
2016
Q2 | $31.3M | Sell |
218,947
-4,379
| -2% | -$625K | 0.01% | 1126 |
|
|
2016
Q1 | $30.5M | Sell |
223,326
-87
| -0% | -$11.4K | 0.01% | 1145 |
|
|
2015
Q4 | $31M | Sell |
223,413
-5,704
| -2% | -$791K | 0.01% | 1100 |
|
|
2015
Q3 | $30.8M | Buy |
229,117
+3,162
| +1% | +$455K | 0.01% | 1127 |
|
|
2015
Q2 | $34M | Sell |
225,955
-1,604
| -0.7% | -$229K | 0.01% | 1130 |
|
|
2015
Q1 | $30.8M | Buy |
227,559
+29,267
| +15% | +$3.63M | 0.01% | 1193 |
|
|
2014
Q4 | $23.9M | Sell |
198,292
-5,288
| -3% | -$609K | 0.01% | 1336 |
|
|
2014
Q3 | $23.1M | Buy |
203,580
+3,507
| +2% | +$416K | 0.01% | 1334 |
|
|
2014
Q2 | $24M | Sell |
200,073
-3,170
| -2% | -$387K | 0.01% | 1361 |
|
|
2014
Q1 | $26M | Sell |
203,243
-19,820
| -9% | -$2.54M | 0.01% | 1302 |
|
|
2013
Q4 | $27.6M | Buy |
223,063
+13,434
| +6% | +$1.64M | 0.01% | 1264 |
|
|
2013
Q3 | $24.6M | Buy |
209,629
+1,789
| +0.9% | +$211K | 0.01% | 1266 |
|
|
2013
Q2 | $23.3M | Buy |
+207,840
| New | +$24.4M | 0.01% | 1267 |
|
Other funds holding BIO
GKIM
Bank of New York Mellon's BIO Position: Q2 2026 in Review
Bank of New York Mellon reduced its Bio-Rad Laboratories Class A (BIO) stake by 10% in Q2 2026, selling an estimated $3.69M and leaving 113,854 shares worth $33.4M. The position accounts for 0.01% of the portfolio, ranked #1312.
Bank of New York Mellon first reported a position in BIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $157M in Q2 2021. 252 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Bank of New York Mellon held 113,854 shares of Bio-Rad Laboratories Class A worth $33.4M as of Q2 2026.
- Bank of New York Mellon sold 13,002 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.69M.
- Bio-Rad Laboratories Class A made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1312 holding.
- Bank of New York Mellon first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Bio-Rad Laboratories Class A position peaked at $157M in Q2 2021.
- 252 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.